chr7-107924095-G-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_002291.3(LAMB1):c.5225-8C>A variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000452 in 1,525,048 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002291.3 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LAMB1 | NM_002291.3 | c.5225-8C>A | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000222399.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LAMB1 | ENST00000222399.11 | c.5225-8C>A | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_002291.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000807 AC: 12AN: 148718Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000166 AC: 29AN: 175066Hom.: 0 AF XY: 0.000138 AC XY: 13AN XY: 93890
GnomAD4 exome AF: 0.0000414 AC: 57AN: 1376330Hom.: 0 Cov.: 30 AF XY: 0.0000352 AC XY: 24AN XY: 682212
GnomAD4 genome AF: 0.0000807 AC: 12AN: 148718Hom.: 0 Cov.: 33 AF XY: 0.0000550 AC XY: 4AN XY: 72664
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 26, 2020 | Has not been previously published as pathogenic or benign to our knowledge; In-silico analysis, which includes splice predictors and evolutionary conservation, is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 17, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at